|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Urinary excretion of apolipoprotein(a) fragmentsin type 1 diabetes mellitus patients显示文摘 | Clodi M Oberbauer R Bodlaj G | 1999 | Metabolism1999，48，： | 1 |
| 2 | Weight gain and metabolic control in newly insulin-treated patients with type 2 diabetes with different insulin regimens显示文摘 | Biesenbach G Bodlaj G Pieringer H | 2006 | Can J Diabetes2006，30，4： | 1 |
| 3 | Re- sponsive and Proactive Market Orientation and Inno- vation Success under Market and Technological Tur- bulence 显示文摘 | BODLAJ M COENDERS G ZABKAR V | 2012 | Journal of Business Economics and Management2012，13，4： | 1 |
| 4 | The impact of a responsive and proactive market orientation on innovation and business performance显示文摘 | Mateja Bodlaj | | 0，，04： | 1 |
| 5 | Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus显示文摘 | Clodi M Oberbauer R Bodlaj G | 1999 | Metabolism1999，48，3： | 1 |
| 6 | Clinical versus histological diagnosis of diabetic nephropathy--is renal biopsy required in type 2 diabetic patients with renal disease?显示文摘 | BIESENBACH G BODLAJ G PIERINGER H | 2011 | QJM2011，104，9： | 1 |
| 7 | Quantification of coronary artery calcification in patients with FH using E-BCT显示文摘 | Hoffmann U Bodlaj G Defiler K | 2001 | Eur J Clin Invest2001，31，6： | 1 |
| 8 | Relationship of non-LDL-bound apo(a),urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function显示文摘 | Cauza E Kletzmaier J Bodlaj G | 2003 | Nephrol Dial Transplant2003，18，8： | 1 |
| 9 | Diurnal variation of arterial stiffness and subendocardial perfusion noninvasivelyassessed using applanation tonometry in healthy young men显示文摘 | Bodlaj G Berg J Biesenbach G | 2005 | Wien Klin Wochenschr2005，117，910： | 1 |
| 10 | Prevalence,severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease显示文摘 | Bodlaj G Berg J Pichler R | | 0，，05： | 1 |
| 11 | Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitns patients显示文摘 | CLODI M OBERBAUER R BODLAJ G | 1999 | Metabolism1999，48，3： | 1 |
| 12 | Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men显示文摘 | Berg J Biesenbach G | 2005 | Wien Klin Wochenschr2005，，： | 1 |
| 13 | Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection显示文摘 | Sandra Beinhardt Judith H. Aberle Michael Strasser Emina Dulic–Lakovic Andreas Maieron Anna Kreil Karoline Rutter Albert F. Staettermayer Christian Datz Thomas M. Scherzer Robert Strassl Martin Bischof Rudolf Stauber Gerd Bodlaj Hermann Laferl Heidemarie | 2012 | Gastroenterology2012，，1： | 1 |
| 14 | Quantification of Coronary Arery Calcification in Patients with F H using EBCT显示文摘 | Hoffmann U Bodlaj G Derfler K | 2001 | Eur J Clin Invest2001，31，： | 1 |
| 15 | Relationship of non-LDL-bound Apo(a),urinary Apo(a) fragments and plasma Lp(a) in patients with impaired renal function显示文摘 | Cauza E Kletzmaier J Bodlaj G | 2003 | Nephrol Dial Transplant2003，18，： | 1 |
| 16 | Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response显示文摘AIM: To investigate relapse predictors in chronic hepatitis C (CHC) patients with end-of-treatment response (ETR), after pegylated interferon-α (PegIFN-α) and ribavirin treatment. METHODS: In a retrospective study we evaluated a spectrum of predictors of relapse after PegIFN-α and ribavirin treatment in 86 CHC patients with ETR. Viral loads were determined with real-time reverse transcrip-tion polymerase chain reaction. Hepatitis C virus geno-typing was performed by sequencing analysis. Patients with genotype 1 were treated for 48 wk with 180 μg PegIFN-α2a or 1.5 μg/kg PegIFN-α2b once weekly plus ribavirin at a dosage of 1000 mg/d for those under 75 kg or 1200 mg/d for those over 75 kg. Patients with geno- types 2 and 3 were treated for 24 wk with 180 μgPegIFN-α2a or 1.5 μg/kg PegIFN-α2b once weekly plus ribavirin at a dosage of 800 mg/d. RESULTS: In all ETR patients, binary logistic regression analysis identif ied absence of complete early virological response (cEVR) (OR 27.07, 95% CI: 3.09-237.26, P < 0.005), serum alkaline phosphatase (ALP) levels prior to therapy < 75 U/L (OR: 6.16, 95% CI: 2.1-18.03, P < 0.001) and body mass index > 26 kg/m2 (OR: 8.27, 95% CI: 2.22-30.84, P < 0.005) as independent predictors of relapse. When cEVR patients were analyzed exclusively, ALP prior to therapy < 75 U/L remained the only predictor of relapse. CONCLUSION: Lower levels of ALP prior to, during and after therapy seem to be associated with a higher risk of relapse in CHC patients with ETR. | Gerd Bodlaj Rainer Hubmann Karim Saleh Tatjana Stojakovic Georg Biesenbach Jrg Berg | 2010 | World Journal of Gastroenterology2010，16，19： | 1 |
| 17 | Relationship of non-LDL-bound Apo (a),urinary Apo (a) fragments and plasma Lp(a) in patients with impaired renal function 显示文摘 | CAUZA E KLETZMAIER J BODLAJ G | 2003 | Nephrol Dial Transplant2003，18，8： | 1 |
| 18 | Type 2 diabetes in patients with end - stage renal disease is not associated with further increased serum inflammatory parameters 显示文摘 | BODLAJ G BERG J PICHLER | 2004 | J Nephrol2004，17，1： | 1 |
| 19 | Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters显示文摘 | Bodlaj G Berg J Pichler R | 2004 | J Nephrol2004，17，1： | 1 |
| 20 | Relationship of non-LDL-bound Apo(a),fragments and plasma LP(a) in patients with impaired renal function显示文摘 | Edmund Cauza Joesf Kletzmaier Gert Bodlaj | 2003 | Nephrol Dial Transplant2003，18，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员